In the SURMOUNT-1 trial examining tirzepatide, hair loss was reported by roughly 56% of participants at higher doses
The other group did not receive any
43 , showed that in non-human primates, injections of the GLP-1R agonist, exendin-4, and the amylin/calcitonin-receptor agonist, salmon calcitonin (sCT), combine to produce a synergistic suppression of food intake
Why It Matters for Kidney Disease 1
The results highlight the considerable capability of the DNZ-NLPs to traverse the BBB, a feature that is critical for the development of therapeutic strategies aimed at neurodegenerative disorders such as HD, offering promising implications for the treatment of central nervous system diseases
Urocortin binds both CRF type 1 and 2 receptors but shows a higher affinity for CRF type 2 receptor than type 1 receptor